scispace - formally typeset
H

Hisashi Umemori

Researcher at Boston Children's Hospital

Publications -  72
Citations -  6826

Hisashi Umemori is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Tyrosine phosphorylation & Synapse. The author has an hindex of 36, co-authored 69 publications receiving 6242 citations. Previous affiliations of Hisashi Umemori include Washington University in St. Louis & Molecular and Behavioral Neuroscience Institute.

Papers
More filters
Journal ArticleDOI

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.

TL;DR: This study completes the mitogenesis-based comparison of receptor specificity of the entire FGF family under standard conditions and should help in interpreting and predicting in vivo biological activity.
Journal ArticleDOI

Characterization of Fyn-mediated tyrosine phosphorylation sites on GluRε2 (NR2B) subunit of the N-methyl-D-aspartate receptor

TL;DR: Tyr-1472 phosphorylation of GluRε2 was greatly reduced infyn mutant mice and significantly enhanced after induction of long term potentiation in the hippocampal CA1 region, suggesting that Tyr-1336, Tyr-1252, and Tyr- 1472 in Glu Rε2 were phosphorylated in human embryonic kidney fibroblasts when co-expressed with active Fyn, and its magnitude became larger in murine brain.
Journal ArticleDOI

Initial events of myelination involve Fyn tyrosine kinase signalling

TL;DR: This paper showed that Fyn tyrosine kinase is activated during the initial stages of myelination and that it is associated with the large myelin-associated glycoprotein (MAG), an adhesion molecule that has been implicated in myelinogenesis.
Journal ArticleDOI

PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-d-aspartate receptor subunit NR2A

TL;DR: Results suggest that PSD-95 is critical for regulation of NMDA receptor activity by Fyn and other Src-familyPTKs, serving as a molecular scaffold for anchoring these PTKs to NR2A.
Journal ArticleDOI

Negative regulation of BMP/Smad signaling by Tob in osteoblasts.

TL;DR: It is shown that Tob, a member of the emerging family of antiproliferative proteins, is a negative regulator of BMP/Smad signaling in osteoblasts and negatively regulates osteoblast proliferation and differentiation by suppressing the activity of the receptor-regulated Smad proteins.